Max Smith
@maxpgx
Clinical #Pharmacogenomics Specialist at MedStar Health & Assistant Prof at Georgetown University Medical Center. he/him
ID: 1370743393
21-04-2013 22:44:54
126 Tweet
295 Takipçi
135 Takip Edilen
New clinical trial results! Ribociclib is used to treat certain breast cancers. We knew CYP3A inhibitors increase ribo levels by 3-fold. But does CYP3A5 genotype predict ribociclib levels? In short, no. A reassuring result for patients and clinicians. Georgetown Cancer Prevention and Control Program PGRN